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Outcomes in Exposure Escalation Experiments
Trina Patel, Cecile Low-Kam, Zhaoxia Ji, Haiyuan Zhang, Tian Xia, Andre E.
Nel, Jeffrey I. Zinc, and Donatello Telesca

Abstract

A fundamental goal in nano-toxicology is that of identifying particle physical and
chemical properties, which are likely to explain biological hazard. The first line of
screening for potentially adverse outcomes often consists of exposure escalation
experiments, involving the exposure of micro-organisms or cell lines to a battery
of nanomaterials. We discuss a modeling strategy, that relates the outcome of an
exposure escalation experiment to nanoparticle properties. Our approach makes
use of a hierarchical decision process, where we jointly identify particles that initiate adverse biological outcomes and explain the probability of this event in terms
of the particle physico-chemical descriptors. The proposed inferential framework
results in summaries that are easily interpretable as simple probability statements.
We present the application of the proposed method to a data set on 24 metal oxides
nanoparticles, characterized in relation to their electrical, crystal and dissolution
properties.
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Abstract
A fundamental goal in nano-toxicology is that of identifying particle physical and chemical
properties, which are likely to explain biological hazard. The first line of screening for potentially adverse outcomes often consists of exposure escalation experiments, involving the exposure
of micro-organisms or cell lines to a battery of nanomaterials. We discuss a modeling strategy,
that relates the outcome of an exposure escalation experiment to nanoparticle properties. Our
approach makes use of a hierarchical decision process, where we jointly identify particles that initiate adverse biological outcomes and explain the probability of this event in terms of the particle
physico-chemical descriptors. The proposed inferential framework results in summaries that are
easily interpretable as simple probability statements. We present the application of the proposed
method to a data set on 24 metal oxides nanoparticles, characterized in relation to their electrical,
crystal and dissolution properties.
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1

Introduction

Nanomaterials are a large class of substances engineered at the molecular level to achieve unique
mechanical, optical, electrical and magnetic properties. Unusual properties of these particles can
be attributed to their small size (with one dimension less than 100nm), chemical composition,
surface structure, solubility, shape and aggregation behavior. One often refers to these particle
characteristics as physico-chemical properties. These very properties allow for increasingly diverse
biological interactions, therefore defining potential hazard concerns. Furthermore, the potential biohazard or these compounds is coupled with increased likelihood of environmental and occupational
release as nanotech applications are ever growing in science, medicine and industry (Nel et al. 2006;
Stern and McNeil 2008).
A first line of screening for potentially hazardous particles is often represented by in-vitro studies,
where micro-organisms or cell cultures are exposed to nanomaterials in a controlled experimental
setting. A typical in-vitro study would measure a biological outcome (LDH, MTS, etc.) in relation to a dose escalation protocol, though, more generally, in-vitro studies aim to measure how
a biological response y(w) changes in relation to a prescription of increased particle exposure w,
varying according to an exposure escalation protocol W, (Meng et al. 2010; George et al. 2011;
Zhang et al. 2011). In Fig. 1, for example, we illustrate a more general design, where 24 metaloxide nanoparticles are monitored in relation to a cellular membrane damage assay (Propidium
Iodide (PI) absorbption), measured contemporaneously over a grid of ten doses and seven hours of
exposure.
A first statistical challenge is encountered in relation to modeling the outcome y(w). Standard
dose-response models focus almost exclusively on dose-escalation protocols and often rely on parametric assumptions, defining dose-response relationships as sigmoidal curves (Ritz 2010) . This
practice is likely not warranted, when considering more general exposure escalation designs. Sigmoidal dose-response curves may be inadequate, for example, if one considers non-lethal assays
(intracellular calcium flux, mitochondrial depolarization, etc.) as they carry assumptions of monotonicity. Furthermore, particle solutions at varying concentrations may result in different particle
aggregation behavior, potentially reducing total cellular exposure at higher concentrations (Hinderliter et al. 2010). These considerations challenge standard dose-response summaries, e.g. effective
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Figure 1: PI uptake of BEAS-2B. Normalized PI uptake associated with exposing BEAS-2B
cells to a library of 24 nano metal oxides. The exposure escalation protocol includes 11 dose levels
and 7 hours of exposure. Each dose by duration combination is replicated 4 times.
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concentrations (ECα), slope coefficients, no adverse effect dose levels, benchmark dose levels, etc.,
and motivate our work. In §2 we replace parametric assumptions about dose-response relationships
with a general smooth surface response model over W and propose a statistical notion of toxicity,
based on mixture modeling (McLachlan and Peel 2000).
Beyond the identification of potentially hazardous particles in the observed sample, from a
predictive and inferential perspective it is important to understand how particles physical and
chemical properties affect the way they interact at the nano-bio interface. The use of a combination of molecular properties to predict a compound’s behavior with respect to biological end-points
is a well accepted concept in the predictive toxicology of chemicals (Schultz et al. 2003). In nanoinformatics, the literature refers to this class of models as nano quantitative structure-activity
relationships (nano-QSAR) models (Shaw et al. 2008; Puzyn et al. 2011; Liu et al. (2011)). Shaw
et al. (2008) present a nano-QSAR model based on hierarchical and consensus clustering. Nanoparticles are classified into groups and clustering patterns are informally compared in relation to ENM
properties, that tend to be assigned to the same class. Puzyn et al. (2011) characterize particle
toxicity in terms of the dose concentration that brought about 50% reduction in bacterial cell viability (EC50). Given this summary, the relationship between EC50 values and particle descriptors
is modeled via linear regression, with selection of covariates based on minimizing a cross validation
error. Similarly, Liu et al. (2011) use logistic regression to model the probability that a particle is
toxic, given covariates. A particle is defined as toxic at a given concentration, based on a statistically significant difference in mean response, as compared to the background response in unexposed
cells.
These techniques often rely on previously defined data summaries and fail to account for the
uncertainty inherent in the estimation of these summaries, when relating them to covariate information. We propose a modeling strategy that provides a definition of toxicity in relation to very
general exposure escalation protocols and, at the same time, represents the probability of toxicity
as a function of particle physical and chemical properties, without the loss of information associated with step-wise procedures. The proposed methodology is appropriate for limited data sets
and easily includes data integration and a framework for advanced dimension reduction through
variable selection.
The remainder of this manuscript is organized as follows. In §2 we introduce the proposed
4

http://biostats.bepress.com/cobra/art101

model. In §3 we discuss parameter estimation and associated inferential details. We illustrate the
application of the proposed methodology in §4 through the analysis of 24 metal-oxide nanomaterials.
We discuss our proposal, potential limitations and extensions in §5.

2

Model Formulation

2.1

A Statistical Definition of Toxicity

Standard protocols for in-vitro assays aim to measure the biological response yij (w) associated with
exposure to particle i, (i = 1, . . . , n). The experiment is replicated m times, with replicates indexed
by j, (j = 1, . . . , m) and the response y is evaluated with respect to a protocol of increased exposure
to nanoparticles indexed by w ∈ W ⊂ Rv+ . Increased exposure is most often implemented as a dose
escalation experiment, in which case v = 1 and W = [0, D], where D is the largest dose. However,
experimental protocols considering both dose escalation and repeated measurements, obtained over
a total exposure duration interval (t ∈ (0, T ]), are becoming more prevalent (George et al. 2011;
Patel et al. 2011). In this last case v = 2 and W = [0, D] × [0, T ]. We assume that raw data have
been normalized and purified from experimental artifacts.
In this general setting, it is indeed difficult to identify an obvious notion of toxicity. In fact,
some biological assays may not address toxicity all-together and simply measure sublethal biological reactions. To be precise, in the absence of reasonable expectations for a standard sigmoidal
dose-response curve, common measures of toxicity, including effective concentrations or hill coefficients are clearly ill-defined. Some progress can be made when considering a test library of n
nanomaterials, by defining toxicity using empirical evidence about the existence of subgroups of
particles. Our approach is based on defining two possible exposure-response categories, as follows:
γi = 0 if
γi = 1 if

particle i is non-toxic
particle i is toxic.

The foregoing model supports both the statistical definition of toxicity, via a mixture approach,
and the formulation of probability statements describing the relationships between toxicity and
nanoparticle properties. Let yi be a vector of measurements collecting all evidence associated with
particle i. For each particle i, we define a sampling model
yi | γi ∼ fiγi (·),

γi ∈ {0, 1},

i = 1, . . . , n.

5

Hosted by The Berkeley Electronic Press

Densities fi0 (·) describe sampling variability over the entire exposure escalation domain W, which
is not distinguishable from the the case of no exposure, therefore allowing for the interpretation
of fi0 (·) as normal biological variation associated with exposure to non-toxic particles. Densities
fi1 (·) describe sampling variability as a function of the exposure escalation protocol W, therefore
allowing for the interpretation of fi1 (·) as biological variation associated with exposure to toxic
particles. If we identify with πi = P (γi = 1) the pre-experimental probability of particle i being
toxic, then for each particle we can readily convert exposure escalation measurements yi into a
probability of toxicity p+
i . Specifically, we have
p+
i = P (γi = 1 | yi , fi0 , fi1 , πi ) =

πi fi1 (yi )
.
(1 − πi )fi0 (yi ) + πi fi1 (yi )

(1)

These quantities offer an interpretable and unequivocal scale of evidence in the classification of
potentially hazardous nanomaterials and even though, to our knowledge, mixture modeling has not
been previously applied in standard dose-response analyses, these techniques have a long history
of proven usefulness in applied statistics (McLachlan and Peel 2000).

2.2

Distributional Assumptions and Semi-parametric Representation

Let yij (w) denote a response corresponding to nanoparticle i (i = 1, ..., n) and replicate j (j =
1, ..., m), at exposure w ∈ W. In practice, observations are obtained over a discrete exposure
sampling grid (w1 , . . . , wk ) ∈ W. However, for ease of presentation and without loss of generality,
we assume that exposure points are defined in a continuous domain. We make precise our definition
of toxicity by introducing the following smooth response model
yij (w) = αi + πi mi (w) + ij (w),

(2)

with ij (w) ∼ N (0, σ2 /τi ) and τi | ν ∼ Gamma(ν/2, ν/2).
Assuming mi (w) ≥ 0 for all w ∈ W and mi (w) > 0 for at least some w ∈ W, the forgoing
representation describes a particle i to be toxic with probability πi . The coefficient αi is interpreted
as the background signal and mi (w) : W → Rp+ is interpreted as the above-background response
hyper-surface, defining signal variation over the exposure-escalation domain W. For the moment
we think of mi (w) as a general positive function defined over a p-dimensional space and describe
practical representation issues later in the manuscript.
6
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The sampling distribution of yij (w) is modeled in terms of the error term ij (w) as a scale
mixture of normal random variables. The error variance is defined in terms of the measurement
error σ2 , and a particle-specific random variance inflation parameter τi , resulting marginally in a
t-distributed error structure (West 1984).
It is convenient to introduce a data-augmented representation of the model in (2). More precisely,
we define a n-dimensional vector of latent binary indicators γ = (γ1 , . . . , γn )0 ∈ {0, 1}n , with
γi | πi ∼ Bern(πi ). Conditioning on γi we have
(


E yij (w) | γi



=

αi
αi + mi (w)

if γi = 0
if γi = 1.

(3)

This representation makes explicit the trans-dimensional nature of the propose model and will be
used as a key component in the construction of a covariate model.

2.3

Modeling Dependence on Covariates

Nanoparticles are often described in terms of their physical and chemical properties. We propose to
use these descriptors to inform particles probabilities of toxicity. Let X denote an n × p covariate
matrix, xi be the i-th row of X and g(·) : [0, 1] → R denote a general link function. We relate
toxicity indicators γi to xi as follows
g P (γi = 1 | λ; xi ) = x0i λ,


(4)

where λ = (λ1 , . . . , λp )0 is a vector of regression coefficients. Common implementations define
g(·) as a probit or logit link, often according to computational or analytical convenience. The
specific interpretation of λ will depend on g(·). However, the vector λ can be generally interpreted
as a summary of how variability in the particle properties explain variability in the probability
of toxicity. This formulation is inherently related to the class of hierarchical mixture of experts
introduced by Jordan and Jacobs (1994).
For regularization purposes, especially in instances where p is large in relation to n, it may
be appropriate to consider covariate subset selection (George and McCulloch 1993). A possible
representation of the problem relies again on data-augmentation, by defining a p-dimensional vector
of variable inclusion indicators ρ = (ρ1 , . . . , ρp )0 ∈ {0, 1}p and a reduced design matrix Xρ , which
only includes the columns of X corresponding to the non-zero elements of ρ. Conditioning on
7
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ρ, we assume g P (γi = 1 | λ, ρ; xiρ ) = x0iρ λρ . In the foregoing model, λρ is interpreted as a


|ρ|-dimensional vector that includes all nonzero elements of λ. Alternative regularization strategies
are easily implemented and may rely, for example, on penalized likelihood formulations (Tibshirani
1996).

2.4

Implementation for a Dose-Duration Escalation Protocol

Our discussion in §2.2 assumed a known exposure response hypersurface mi (w) : W → R+ . Here
we discuss practical representation details in relation to a dose-duration escalation protocol. We
illustrate this specific case as experimental protocols designed to monitor a biological outcome
over several doses and durations of exposure to nanomaterials are becoming increasingly prevalent
(George et al. 2011; Patel et al. 2011). Furthermore, standard dose escalation protocols are easily
obtained as a special case of this more general design.
Specifically, we consider the case of W = [0, D] × (0, T ], so that the dose-response surface
mi (w) = mi (d, t) : [0, D] × [0, T ] → R+ spans two dimensions: dose d ∈ [0, D] and time t ∈ [0, T ].
To ensure likelihood identifiability we require, that mi (d = 0, t = 0) = 0.
It is often appropriate to think of mi (·) as a smooth function, therefore non-parametric representations may rely on two-dimensional P-splines (Lang and Brezger 2006).
We consider the approximation of mi (d, t) using sd and st equally spaced interior knots
0 < η1d < η2d , ... < ηsd −1 < ηsd < D;

and

0 < η1t < η2t , ... < ηst −1 < ηst < T.

Each set of interior knots generates a corresponding set of Md = sd + `, and Mt = st + `, B-spline
basis functions of order ` [ref.]. Let Bm (·) denote the mth basis and β i = (βi1 , .., βi,md mt , ...βi,Md Mt )0
be a (Md Mt )-dimensional vector of spline coefficients. The function mi (d, t; β i ) can then be represented as the tensor product of one-dimensional B-splines:
mi (d, t; β i ) =

M
Pd

M
Pt

md =1 mt =1

βi,md mt Bmt (t)Bmd (d);

i = 1, . . . , n.

(5)

Using the foregoing representation, the identifiability restriction mi (d = 0, t = 0; β i ) = 0, is
implemented by fixing βi1 = 0, for all particles. Similarly, positivity is implemented by restricting
β i ∈ RMd Mt + for all i = 1, . . . , n.
Model complexity and flexibility in mi (d, t) is a function of the spline order ` and the number
of interior knots sd in the dose and st in the time domain. Typical implementations rely on cubic
8
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splines ` = 4 and a large number of interior knots. Automatic smoothing is then obtained via
regularization procedures that include penalized likelihood (Eilers and Marx 1996) or smoothing
priors (Besag and Kooperberg 1995, Lang and Brezger 2004).

3

Estimation and Inference

3.1

Bayesian Hierarchical Representation

Estimation of the model parameters and inference can be carried out using several inferential
strategies. In particular, penalized likelihood estimation could be implemented in order to account
for regularization of the exposure response surface and regression coefficients in the covariate model.
A more natural representation of the proposed probability scheme is based on hierarchical models
(Carlin and Louis 2000). This choice is guided by the fact that the proposed model is defined in
terms of large vectors of related parameters and Bayesian hierarchical models lead to shrinkage
estimates with good statistical properties (Berger 1985).
In this article we consider the following representation.
Stage 1: Sampling Model. We rewrite the model first introduced in (2), conditioning on all coefficients defining its semi-parametric structure. We have,
yij (w) | γi , αi , β i , σ2 , τi ∼ N αi +I(γi = 1)mi (w, β i ), σ2 /τi , i = 1, . . . , n; j = 1, . . . , m; w ∈ W.


(6)
Stage 2: Particle Level Model. At the level of particle i, we specify a model for the toxicity indicators γi and the response surface coefficients β i .
The probability of toxicity is assumed to depend on a subset of covariate Xρ , indexed by inclusion
indicators ρ. We follow Albert and Chib (1993) and introduce a n-dimensional vector of latent
variables z = (z1 , . . . , zn )0 , so that we can write
γi | zi = I(zi > 0),

and zi | ρ, λ ∼ N (x0iρ λρ , 1).

(7)

The foregoing implementation defines a probit link for γ and represents covariate selection as
introduced in §2.3.
Distributional assumptions for β i are based on considerations of smoothness and conjugacy
(Besag and Kooperberg 1995, Lang and Brezger 2004). Specifically, we use a prior based on the
9
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Kronecker product of penalty matrices defined in of the dose and time domain, so that
β i ∼ NMd Mt 0, Σβ = σβ2 (Kd ⊗ Kt )−1 .


(8)

The penalty matrices Kd : Md × Md and Kt : Mt × Mt , are constructed as follows:


1
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 1


Kd =  0
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(9)

The matrix Kt is similarly constructed. The resulting penalty matrix leads to a rank deficient covariance matrix. However, adding a small positive constant to the first and last elements reinstates
propriety without fundamentally changing the spacial smoothing properties of the proposed distribution. Detailed derivations and alternatives are discussed in (Clayton 1996, Lang and Brezger
2004).
For completeness the prior on the background level is chosen to be conjugate and non informative,
so that αi | σ2 , τi ∼ N (0, cσ2 /τi ), where c is set to a large value.
Stage 3: Priors. Our choice of priors is guided by conditional conjugacy as well as principles of
multiplicity correction. In particular we consider a Zellner g-prior [ref.] for the covariate model
coefficients λρ | ρ ∼ N (0, gρ (Xρ0 Xρ )−1 ) and an exchangeable Bernoulli prior for the inclusion
indicators ρ, so that p(ρ | ψ) = ψ |ρ| (1 − ψ)p−|ρ| . As described by Lee et al. (2003), choosing
small values for ψ, leads to parsimonious models by restricting the number of covariates included.
The values of ψ can also be tuned to include prior knowledge about the importance of certain
physicochemical properties. Most commonly, a prior is placed on ψ, such that ψ ∼ Beta(aπ , bπ ),
and multiplicity correction is achieved automatically, as described by Scott and Berger (2006). A
data dependent gρ is often recommended and we follow Fernandez et al. (2001) in setting gρ =
max(n, |ρ|2 ).
Finally, we complete the model by specifying conditionally conjugate prior distributions on

10
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variance components

1

1/σ2 ∼ Gamma(a , b ),

3.2

1/σα2 i

1/σβ2 ∼ Gamma(aβi , bβi ).

∼ Gamma(aαi , bαi ),

Posterior Simulation via MCMC

We base our inference on Markov Chain Monte Carlo (M CM C) simulations. Closed-form full
conditional distributions are available for all parameters, therefore the proposed posterior simulation
algorithm utilizes a Gibbs sampler to directly update parameters component-wise (Geman and
Geman 1984, Gelfand and Smith 1990).
Specific steps in the simulation are inherently trans-dimensional and some care is needed in the
identification of Gibbs components to be updated jointly. In particular, we implement a chain with
transition kernels moving toxicity indicators γ and covariate inclusion indicators ρ, always with
respect to their marginal posterior distributions, integrating over β and λ respectively. Given γ
and ρ, the model structure and dimension is fully determined and other model parameters can be
updated in a standard fashion. The proposed sampling scheme can be summarized as follows.
1. Trans-dimensional updates
We begin by drawing γ from its marginalized conditional distribution, obtained by integrating the
conditional posterior over β. More precisely, for each particle i (i = 1, . . . , n)
p(γi |

yi , α, λ, σ2 , τ , ρ)

where defining Ωβi =

τi
Hi0 Hi
σ2

∝

Z

p(yi | β i , α, σ2 , τ )p(β i | γi , Σβ ) dβ i p(γi | λ, ρ);

+ Σ−1
β , gives us
−1



P (γi = 1 | yi , α, λ, σ2 , τ , ρ) = 


Φ(−x0iρ λρ )



Φ(x0iρ λρ ) |Σβ |

− 12

− 12

|Ωβi |



exp

τi2
2σ4

0
ỹi0 Hi Ω−1
βi Hi ỹi


 + 1


.

In the foregoing formula, Φ(·) is the cdf of a standard normal distribution. The derivation of this
result, and precise construction of the vectors ỹi and matrices Hi are provided in Appendix A.
A similar scheme was adapted for sampling from ρ | λ, z, γ. The marginalized conditional
1
We assume, x ∼ Gamma(a, b) denotes a Gamma distributed random quantity with shape a and rate b, such that
E(x) = a/b.

11
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distribution of ρ, obtained by integrating over λ is given by
p(ρ | z, ψ) ∝
∝

Z

√

p(z | ρ, λ)p(λ | ρ)dλ p(ρ | ψ)
1
(1+gρ )

exp

h

gρ
0
0
−1 0
2(1+gρ ) z Xρ (Xρ Xρ ) Xρ z

i

ψ |ρ| (1 − ψ)1−|ρ| .

2. Fixed dimensional updates.
Given the current state of the latent indicators γ, response surfaces are uniquely defined as in (3).
Posterior sampling here is standard, and proceeds by updating spline coefficients β i , background
response parameters αi , and variance parameters τi and σ2 and σβ2 , from their full conditional distributions via direct simulation. Similarly, given latent indicators ρ, the covariate model is uniquely
defined as in (7). Again, posterior sampling is standard and proceeds by updating regression coefficients λρ from p(λρ | ρ, z), and, z from p(z | y, λ, ρ), via Gibbs sampling. Full conditional
distributions are given in Appendix A.

4

Structure Activity Relationships of Nano Metal Oxides

4.1

Case Study Background

We illustrate the proposed methodology by analyzing data on human bronchial epithelial cells
(BEAS-2B), exposed to a library of 24 nano metal-oxides including: ZnO, CuO, CoO, Fe2 O3 ,
Fe3 O4 , WO3 , Cr2 O3 , Mn2 O3 , Ni2 O3 , SnO2 , CeO2 , Al2 O3 , among others. We consider a measure of
cellular membrane damage as measured by Propidium Iodine (PI) uptake. Specifically, cell cultures
are treated with Propidium Iodide (PI) and in cells with damaged membranes PI is able to permeate
the cell and bind to DNA, where it causes the nucleus to emit a red florescence. Each sample was
also stained with a Hoechst dye, which causes all cell nuclei to emit a blue florescence, and allows
for a count of the total number of cells. An analysis of the fluorescence readout, measured at
varying wavelengths, results in a measure of the percentage of cells positive for each response. The
outcome is measured over a grid of eleven doses and seven times (7-hours) of exposure over four
replicates. The final response was purified from experimental artifacts and normalized using a logit
transformation (Fig. 1).
All particles were characterized in terms of their size, dissolution, crystal structure, conduction
energies, as well as many other particle descriptors (Zhang et al. 2012). Burello and Worth (2011)
hypothesized that comparing the conduction and valance band energies to the redox potential of the
12
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reactions occurring within a cell could predict nanoparticle toxicity of oxides. The normal cellular
redox potential is in the range (-4.12 to -4.84 Ec). The conduction band energy of a particle is a
measure of the energy sufficient to free an electron from an atom, and allow it to move freely within
the material. Therefore, we are interested in the relationship between particles with conduction
band energies within and outside the range of the cellular redox potential and their cytotoxicity
profiles.
Another measure of interest is the metal dissolution rate of a particle. Particles that are highly
soluble have the ability to shed metal ions, which can lead to nanoparticle toxicity (Xia et al. 2008;
Xia et al. 2011; Zhang et al. 2012). Other potential risk factors include the particle primary size, a
measure of the crystalline structure (b(Å)), lattice energy (∆Hlattice ), which measures the strength
of the bonds in the particles, and the enthalpy of formation (∆HM en+ ), which is a combined measure
of the energy required to convert a solid to a gas and the energy required to remove n electrons
from that gas.

4.2

Case Study Analysis and Results

The model described in §2 was fit to the metal-oxide data-set described in the previous section. We
placed relatively diffuse Gamma(.01, .01) priors on the 1/σ parameter, Gamma(1, .1) priors on
all remaining precision parameters, and c = 100 as the prior variance inflation constant of αi . We
also placed a prior distribution on the degrees of freedom parameter ν, for the t-distributed error
described in Section 2.2. Specifically, the prior was modeled using a discrete uniform distribution
on 1,2,4,8,16, and 32 degrees of freedom (Besag and Higdon 1999). Finally, for the covariate model
we consider a default U (0, 1) prior for ψ.
In structuring the covariate matrix X, we model log(dissolution) in a non-linear fashion as a
spline function with a change point at log(dissolution) of 2.3. This choice is motivated by the fact
that the nanoparticle library is really comprised of two separate classes, a set of particles with low
dissolution and two particles (ZnO and CuO) with high dissolution, therefore it is wise to allow
for a discontinuity at the boundary. Conduction band energy was coded as a binary covariate
(I{Ec ∈ (-4.12, -4.84}), and all other ENM characteristics described above as continuous linear
predictors.
Our inferences are based on 20,000 MCMC samples from the posterior distribution, after dis-

13
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Figure 2: Fitted response surfaces for CuO, Al2 O3 , CeO2 , CoO, Fe2 O3 , Fe3 O4 , Mn2 O3 ,
Gd2 O3 , HfO2 , ZnO, In2 O3 , and La2 O3 ENMs. Estimated smooth response surfaces, where
the color red represents response values corresponding to lower time points and the color black
represents response values corresponding to higher time points.
14
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Figure 3: Posterior mean probability of toxicity for each ENM. Particles with a probability
of toxicity greater then .5 are indicated in red.
carding a conservative 60,000 iterations for burn-in. MCMC sampling was performed in R version
2.10.0, and convergence diagnostics were performed using the package CODA (Convergence Diagnostics and Output Analysis), (Plummerm et al. 2006).
Figure 2 illustrates data and the posterior expected dose-time response for a sample of particles
examined in this HTS study. Figure 3 provides a plot of the estimated probability of toxicity for
each of the 24 nanomaterials. We find that CuO, Mn2 O3 , ZnO, Cr2 O3 , CoO, CO3 O4 , and Ni2 O3
nanomaterials have a pronounced dose/time effect, as compared to the other 17 materials. These
seven particles all have posterior mean probabilities of toxicity above 0.5 (Fig. 3), suggesting that
they are highly likely to induce cytotoxicity.
An estimate of the inclusion probability, ρ̂ was used to select a single covariate model. Specifically we follow Scott and Berger (2006) by selecting the median model, that is including all
covariates for which ρ̂k > 0.5, (k = 1, . . . , p). The median model included log(metal dissolution)
and conduction band energy. Table 1 provides estimates of posterior inclusion probabilities and
model averaging posterior summaries. Results for the median model are reported in Table 2, where
we provide posterior summaries for the model including conduction band energy and log(metal
dissolution rate) alone.
These regression coefficients are easily interpreted as simple probability statements related to
changes in the probability of toxicity, as one varies a particle’s physical and chemical properties.
15
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Parameter
Intercept
Conduction Band Energy
log(Metal Dissolution Rate)<2.3
log(Metal Dissolution Rate)>2.3
log(Primary Size)
log(Crystal Structure (b(Å)))
log(Enthalpy of Formation (∆HM en+ ))
log(Lattice Energy (∆Hlattice ))

Inclusion Probability
1.00
0.77
0.69
0.69
0.31
0.35
0.38
0.36

Posterior Summaries
-0.50(-16.17,18.31)
1.62( 0.00, 3.81)
0.07( -0.19, 0.39)
2.81( -0.19,12.90)
0.00( -0.72, 0.71)
-0.03( -2.11, 1.97)
-0.20( -2.38, 1.37)
-0.18( -1.89, 2.10)

Table 1: Posterior summaries for regression coefficients corresponding to the model
which includes predictors for seven different ENM physicochemical properties. Posterior inclusion probabilities as well as posterior mean and associated 95% posterior intervals are
provided for the model regression coefficients.

Parameter
Intercept
Conduction Band Energy
log(Metal Dissolution Rate)<2.3
log(Metal Dissolution Rate)>2.3

Posterior Summaries
-1.22(-2.45,-0.20)
2.02( 0.49, 3.75)
0.11(-0.19, 0.41)
3.52(-0.18, 8.49)

Table 2: Posterior summaries for regression coefficients corresponding to the final
model. The final model includes model includes predictors for to conduction band energy and
log(metal dissolution rate). Posterior mean estimates and associated 95% posterior intervals are
provided for the model regression coefficients.
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Figure 4 illustrates summary plots of the posterior probability of toxicity (with 95% credible bands)
as a function of conduction band energy and metal dissolution. The bottom panel of Figure 4
provides the posterior mean probability of toxicity, as a function of both conduction band energy
and log(metal dissolution). We find that conduction band energies inside the redox potential of the
cell, predict high probability of cytotoxicity. Similar inference is drawn for particles with a high
metal dissolution rate. The mechanistic interpretation of our findings is based on the idea that
oxidizing and reducing substances can create an imbalance in the normal intracellular state of the
cell, either by the production of oxygen radicals or by reducing antioxidant levels. In particular,
the potential for oxidative stress might be predicted by comparing the energy structure of oxides,
as measured by their conduction and valance band energy levels, to the redox potential of the cell.
When these two energy levels are comparable, it can possibly allow for the transfer of electrons,
and subsequent imbalance in the normal intracellular state. Our model confirms the substantive
findings in Burello and Worth (2011) and Zhang et al. (2012)).
Finally, we assess goodness of fit using posterior predictive checks. The conditional predictive
ordinate (CP O), as defined by Geisser (1980), is the predictive density of observation `, given
all other observations, and can be used as diagnostic tool for detecting observations with poor
model fit. Large values of -log(CP O) indicate observations that are not being fitted well. The top
panel of Figure 5, provides a plot of -log(CPˆ Oi (d, t)) for our final model. In general, low values
of -log(CP Oi (d, t)) indicate good model fit. The middle panel indicates that the largest values
of -log(CPˆ Oi (d, t)) tend to be observations with large exposure times. This is expected, as cell
death is sometimes followed by the dissolution of cell nuclei, hindering the measurement of cellular
response. Next, we provide plots of the probability integral transform histogram for the entire
model, as described by Gneiting et al. (2007). The plot is provided in the bottom panel of Figure 5,
and visual assessment indicates that it is close to uniformity, suggesting relatively good posterior
predictive calibration. Additional summaries and formal definition of these diagnostic tools are
detailed in Appendix B.

17
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Figure 4: Posterior summaries of the probability of toxicity as a function of conduction
band energy and metal dissolution. (Top) Posterior mean (black) and 95% posterior intervals
(red) for the probability of toxicity as a function of log(metal dissolution rate), given conduction
band energy outside the range of the cell redox potential. (Middle) Posterior mean (black) and
95% posterior intervals (red) for the probability of toxicity as a function of conduction band energy,
given no metal dissolution. (Bottom) Posterior mean probability as a function of conduction band
energy and log(metal dissolution rate). Red colored regions indicate greater probability of toxicity,
whereas blue colored regions indicate low probability of toxicity.
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Figure 5: Graphical model diagnostics. (Top) Estimate of − log(cpoi (d, t)) for detecting observations with poor model fit. (Middle) Plot of -log(cpoi (d, t)) as a function of dose and time,
indicating any relationship between outlying observations and the administered dose or duration of
19
exposure. (Bottom) Probability Integral Transform assessing empirical calibration of the posterior
predictive distribution.
Hosted by The Berkeley Electronic Press

5

Discussion

In this manuscript we propose a modeling framework for general exposure escalation experiments,
based on a newly defined measure of toxicity. Precisely, we consider the representation and estimation of the probability that each particle or compound would initiate adverse biological reactions.
This measure is seamlessly integrated into very general exposure escalation protocols, including
multi-dimensional models, that account for dose and duration kinetics jointly. Furthermore, the
proposed summary is warranted with respect to non-lethal biological outcomes, as well as for experiments in nano-toxicology, where particle aggregation behavior may hinder reasonable expectations
of sigmoidal dose response trajectories.
One dimension that is potentially lost in the model, if implemented in terms of a general
exposure-response surface, is the possible interpretation of standard dose-response parameters for
canonical risk assessment. However, if parametric assumptions are warranted by the experimental setting, our model is easily represented in terms of these standard parametric formulations.
Furthermore, most quantities related to standard risk assessment parameters can still be easily
obtained numerically, by post-processing posterior samples.
We show how the probability of toxicity can be used to link nanomaterials physicochemical properties to non-linear and multidimensional cytotoxicity profiles, while accounting for the uncertainty
in the estimation of this summary. This is in stark contrast with the current practice of step-wise
analyses. The proposed methodology is also appropriate for limited data sets, as it includes data
integration and a framework for advanced dimension reduction through variable selection. We
account for the non-robust nature of the data by allowing for particle specific variance inflation,
resulting in a t-distributed model for the error structure. Finally, the hierarchical representation
of the model allows for easy and robust estimation, as well as rich inference and informative model
diagnostics.
Our proposal is easily extended to account for multiple cytotoxicity parameters, in the form of
multivariate dependent observations. A reasonable dependence scheme can, for example, assume
data to be dependent within outcome and particle, as well as between outcomes for the same
particle. Further generalizations may relax the assumption of linearity relating particle properties
to probabilities of toxicity. This exercise would however, find justification only if larger sets of
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nanomaterial libraries become available for biological testing.
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